Report: WHO overstated H1N1 threat; Big drug company payroll
June 4, 2010
Aljazeera- A joint report into the handling of the H1N1 outbreak has found that some scientists who advised governments to stockpile drugs, had previously been on the payroll of big drug companies.
The scientists were working for the World Health Organisation, whose decision to name the flu a “pandemic” is also coming under scrutiny from European investigators.
The WHO stands accused of exaggerating the dangers of the H1N1 outbreak, which emerged in April last year.
Laboratory tests have confirmed more than 18,000 deaths from H1N1 infection, according to WHO figures, but the virus has turned out to be less deadly than feared.
Also, symptoms suffered by most people infected with the virus have been mild.
The WHO initially urged rapid development of treatments and vaccines, fearing the virus had the potential to kill millions.
As a result wealthy countries spent billions on medicines which many believe are now unnecessary.
Across Europe, governments are now trying to resell their stockpiles of swine flu vaccine.
An emergency committee of the WHO has been waiting for signs of how the virus is developing in the southern hemisphere winter before making a full pronouncement on its state.
The committee, composed of 15 external advisers, believes it is critical for countries to maintain vigilance concerning the pandemic, including necessary public-health measures for disease control and surveillance, Margaret Chan, the WHO director-general, has said in a statement.
It will be recalled that towards the end of last year, Heath-care workers in the US waged a big battle against being forced to accept these vaccines during the so-called pandemic. –Time
Chan said that pandemic flu activity was expected to continue, and the committee would meet again by mid-July to review the status of the outbreak once more data from the winter influenza season in the southern hemisphere was available.
The panel met on Tuesday, but Chan delayed any announcement until Thursday as the committee, whose members were spread around the world for the meeting by teleconference, put the final touches to the wording of their recommendation.
Chan’s decision, based on the committee’s recommendation, means that the outbreak, widely known as swine flu, remains at phase 6 on the WHO’s pandemic scale, which has been at the top level of 6 since June 2009.
‘Virus still a threat’
WHO experts say the virus remains a threat to some vulnerable people, notably pregnant women, young children and those with respiratory problems, and such groups would continue to need vaccinations.
“We’re still in the pandemic,” Gregory Hartl, a WHO spokesman, said.
Fiona Godlee, the editor-in-chief of the British Medical Journal (BMJ), told Al Jazeera the findings were “not surprising” but that the public should be “shocked by this”.
“This was a major decision that affected governments around the world, vast sums of public money and private profit, and we need to really understand exactly the extent to which WHO’s advice was influenced by the pharmaceutical industry,” she said.
“The investigation by the BMJ suggests that there was substantial influence at a number of key stages in the declaration of the pandemic, the definition of the pandemic, the triggering of vaccine contracts around the world and advice to government to stockpile large numbers of expensive antiviral drugs.
“The extent of misjudgment was really very profound in this case.”
But Hartl of WHO said: “It is predicted that H1N1 will continue to be the primary or overwhelming virus among influenza viruses for quite a while.